Navigation Links
Paul Capital Healthcare to Participate in Panel on Non-Traditional Forms of Financing
Date:5/15/2009

NEW YORK and ATLANTA, May 15 /PRNewswire/ -- Paul Capital Healthcare today announced that New York-based partner, John Leone, will participate in a panel on non-traditional forms of financing at the 2009 BIO International Convention. Designed to familiarize participants with how to evaluate non-dilutive financing options that can meet the needs of companies at diverse stages of development, the panel, "Non-dilutive and Other Non-traditional Forms of Financing," is scheduled for 2:00-3:30 pm ET, Wednesday, May 20th. The panel, presented as part of the Biotechnology Industry Organization International Convention, will be held at the Georgia World Congress Center in Atlanta.

Relevant at a time when IPOs are hard to execute and equity valuations uncertain, this panel will explore various models for obtaining capital for product development other than through equity finance. Mr. Leone will provide an overview and case studies of royalty and structured revenue financing transactions, as well as discuss how these financing strategies are critical for biotechnology companies in the months ahead.

"In the current financial environment, obtaining capital from traditional equity and debt markets is exceedingly difficult for small- and mid-size biotechnology companies," said John Leone, partner at Paul Capital Healthcare. "The total value of biotechnology financing transactions in 2008 was down 50% compared with 2007, and data from the first quarter of 2009 suggest that the environment will remain challenging over the near term. At the same time, increasing development costs coupled with favorable healthcare market dynamics continue to fuel the funding needs of biotechnology companies. Fortunately, there are a variety of alternative financing strategies available to companies across all stages of development, and this panel will provide insight into viable and available methods for accessing capital from investors who are actually doing deals in today's market. Both royalty monetization and revenue interest financing transactions, which are non-dilutive and can be tailored to meet the needs of individual companies, will be discussed."

About Paul Capital Healthcare and Paul Capital Partners

Through its funds, Paul Capital Healthcare is one of the largest dedicated healthcare investors globally, with more than $1.6 billion in equity capital commitments and debt facilities under management. Combined, the Paul Capital Healthcare funds have invested more than $965 million in the pharmaceutical, biotechnology, and medical device sectors. These investments are focused on commercial stage companies and products, and consist of investments in the form of royalties, revenue interests, debt and equity. Additional information on Paul Capital Healthcare can be found at www.paulcapitalhealthcare.com. Paul Capital Partners manages nearly $6.6 billion in equity capital commitments for its three investment platforms, which include Paul Capital Healthcare, Private Equity Secondaries and Top Tier Fund-of-Funds. The firm has offices in New York, San Francisco, Paris, London, Hong Kong, and Sao Paolo.

    Contact Information:
    Paul Capital Healthcare
    John Leone, Partner
    Tel: (646) 264-1144
    Email: jleone@paulcap.com

    Lazar Partners
    Stephanie Seiler
    Tel: (206) 713-0124
    Email: sseiler@lazarpartners.com
    Susan Rood
    Tel: (212) 843-0210
    Email: srood@lazarpartners.com


'/>"/>
SOURCE Paul Capital Healthcare
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
2. AtriCure to Present at Roth Capital Partners 2007 New York Conference
3. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
4. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
5. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
6. iCAD to Present at Americas Growth Capital 4th Annual Emerging Growth Conference
7. Pharsight Files Application for Nasdaq Capital Market Listing
8. Advanced Life Sciences Joins NASDAQ Capital Market
9. Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics
10. Bally Total Fitness Emerges From Chapter 11 and Closes Transaction with Harbinger Capital Partners Funds
11. Caxton-Iseman Capital Acquires Conney Safety Products, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... ... May 23, 2016 , ... ... research on discriminated minorities’ quality of life and is currently focusing on ways ... advocacy documentaries to be tested through research to find out whether watching them ...
(Date:5/23/2016)... (PRWEB) , ... May 23, ... ... and security executive networking and relationship-marketing firm, announced today that nominations will ... Information Security Executive® (ISE®) Northeast Awards. , Awards include the Information Security ...
(Date:5/23/2016)... San Francisco, California (PRWEB) , ... May 23, 2016 , ... ... that their organization of noteworthy California winemakers will close operations at the end of ... importance of balance in California wine,” Hirsch said. “As we look back on what ...
(Date:5/23/2016)... ... 23, 2016 , ... Hospice of Westchester (HOW), an organization ... 24 years, recently hosted its sixth annual Celebration of Life Memorial Butterfly Release. ... each concluding with the release of Monarch butterflies that honored the memories of ...
(Date:5/23/2016)... (PRWEB) , ... May 23, 2016 , ... Octo Consulting ... to the federal government, is proud to announce they have recently won two awards ... International’s 2016 Small Business of the Year. Additionally, Octo VP of Civilian Affairs, ...
Breaking Medicine News(10 mins):
(Date:5/19/2016)... , May 19, 2016 ... titled, World Biopsy Devices Market Opportunities and Forecasts, ... devices market generated $1,621 million in 2015. The ... 2015, and is expected to maintain this trend ... http://photos.prnewswire.com/prnh/20140911/647229 ) , To ...
(Date:5/19/2016)... Calif. , May 19, 2016  Global Blood ... company developing novel therapeutics for the treatment of grievous ... new GBT440 data will be presented in a poster ... Congress in Copenhagen . The ... 1/2 GBT440-001 study in sickle cell disease (SCD), including ...
(Date:5/19/2016)... , May 19, 2016  IBM,s (NYSE:   IBM ... international study to identify drug candidates to cure Zika, ... has declared a global public health emergency. ...  anyone with a computer or Android device to join ... expertise or money to help; they simply  run an ...
Breaking Medicine Technology: